Could a simple ultrasound replace costly scans for liver cancer patients?

NCT ID NCT06261814

Recruiting now Diagnosis Sponsor: john eisenbrey Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether contrast-enhanced ultrasound (CEUS) can accurately show how well liver tumors respond to a treatment called chemoembolization (TACE). Currently, doctors wait 1-2 months after TACE and use MRI or CT scans to check results. CEUS can be done during the procedure itself, potentially giving faster and cheaper answers. About 266 adults scheduled for TACE will receive CEUS, and researchers will compare its accuracy to standard imaging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver and intrahepatic bile duct neoplasm Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER NEOPLASMS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sidney Kimmel Cancer Center at Thomas Jefferson University
RECRUITING

Philadelphia, Pennsylvania, 19107, United States